Total Payments
$4,583
2024 Payments
$1,810
Companies
27
Transactions
249
Medicare Patients
3,338
Medicare Billing
$458,530
Payment Breakdown by Category
Food & Beverage$4,583 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,583 | 249 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $979.69 | 41 | $0 (2024) |
| ABBVIE INC. | $695.33 | 43 | $0 (2024) |
| Lilly USA, LLC | $456.02 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $376.33 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $296.49 | 19 | $0 (2024) |
| Novo Nordisk Inc | $287.85 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $215.05 | 9 | $0 (2021) |
| GlaxoSmithKline, LLC. | $166.75 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $162.05 | 10 | $0 (2024) |
| PFIZER INC. | $148.10 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,810 | 88 | AstraZeneca Pharmaceuticals LP ($542.34) |
| 2023 | $1,691 | 96 | ABBVIE INC. ($488.69) |
| 2022 | $45.40 | 3 | Janssen Pharmaceuticals, Inc ($32.76) |
| 2021 | $308.05 | 21 | AbbVie Inc. ($94.31) |
| 2020 | $228.22 | 15 | Janssen Pharmaceuticals, Inc ($101.50) |
| 2019 | $375.32 | 20 | NOVARTIS PHARMACEUTICALS CORPORATION ($153.47) |
| 2018 | $29.94 | 2 | PFIZER INC. ($15.00) |
| 2017 | $94.40 | 4 | Abbott Laboratories ($48.90) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Biological | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $110.58 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Biological | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: DIABETES | ||||||
| 09/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Obesity | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Endocrinology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Biological | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,240 | 2,250 | $475,109 | $200,562 |
| 2022 | 8 | 510 | 797 | $282,654 | $64,385 |
| 2021 | 10 | 888 | 1,218 | $579,237 | $108,903 |
| 2020 | 9 | 700 | 1,015 | $445,332 | $84,681 |
Total Patients
3,338
Total Services
5,280
Medicare Billing
$458,530
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 176 | 386 | $81,441 | $38,354 | 47.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 202 | 484 | $86,350 | $31,976 | 37.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 97 | 490 | $85,750 | $30,486 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 155 | 193 | $48,250 | $28,941 | 60.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 166 | 186 | $47,010 | $20,172 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 130 | $26,000 | $13,739 | 52.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 123 | 139 | $28,495 | $9,405 | 33.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 35 | $10,850 | $6,197 | 57.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $17,433 | $5,492 | 31.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 56 | 57 | $22,375 | $5,472 | 24.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 39 | 41 | $8,200 | $4,571 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 36 | $6,300 | $2,765 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,675 | $2,285 | 48.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 18 | 18 | $1,980 | $708.70 | 35.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 137 | 324 | $123,556 | $28,092 | 22.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 81 | 163 | $42,640 | $9,871 | 23.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 89 | 94 | $35,875 | $8,483 | 23.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 99 | 99 | $25,669 | $5,988 | 23.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $15,555 | $3,642 | 23.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $13,961 | $2,985 | 21.4% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 29 | 34 | $14,186 | $2,893 | 20.4% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 33 | 41 | $11,212 | $2,431 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 295 | 484 | $207,152 | $43,414 | 21.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 239 | 368 | $115,184 | $22,900 | 19.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 75 | 76 | $53,200 | $13,611 | 25.6% |
About Dr. Nga Molte, MD
Dr. Nga Molte, MD is a Hospitalist healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1114267853.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nga Molte, MD has received a total of $4,583 in payments from pharmaceutical and medical device companies, with $1,810 received in 2024. These payments were reported across 249 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,583).
As a Medicare-enrolled provider, Molte has provided services to 3,338 Medicare beneficiaries, totaling 5,280 services with total Medicare billing of $458,530. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties General Acute Care Hospital, General Acute Care Hospital
- Location Brick, NJ
- Active Since 02/17/2013
- Last Updated 01/27/2020
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114267853
Products in Payments
- FARXIGA (Drug) $562.10
- XARELTO (Drug) $376.33
- MOUNJARO (Drug) $272.34
- QULIPTA (Drug) $248.46
- JARDIANCE (Drug) $225.37
- AIRSUPRA (Drug) $223.29
- ENTRESTO (Drug) $215.05
- VRAYLAR (Drug) $208.81
- XIFAXAN (Drug) $162.05
- Wegovy (Drug) $159.07
- TRELEGY ELLIPTA (Drug) $154.53
- ELIQUIS (Drug) $128.37
- Cologuard Collection Kit (Device) $126.54
- LOKELMA (Drug) $105.83
- ZEPBOUND (Drug) $103.18
- DALVANCE (Drug) $92.02
- UBRELVY (Drug) $83.54
- Ozempic (Drug) $77.87
- Veozah (Drug) $77.53
- TRINTELLIX (Drug) $70.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.